University of Cincinnati, Department of Molecular Genetics, Biochemistry, and Microbiology, Cincinnati, Ohio, USA
Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, Cincinnati, Ohio, USA.
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02209-18. Print 2019 Apr 15.
Herpes simplex virus (HSV) establishes latency in neurons of the peripheral and central nervous systems (CNS). Evidence is mounting that HSV latency and reactivation in the nervous system has the potential to promote neurodegenerative processes. Understanding how this occurs is an important human health goal. In the mouse model, viral reactivation in the peripheral nervous system, triggered by hyperthermic stress, has been well characterized with respect to frequency and cell type. However, characterization of reactivation in the CNS is extremely limited. Further, it remains unclear whether virus reactivated in the peripheral nervous system is transported to the CNS in an infectious form, how often this occurs, and what parameters underlie the efficiency and outcomes of this process. In this study, reactivation was quantified in the trigeminal ganglia (TG) and the brain stem from the same latently infected animal using direct assays of equivalent sensitivity. Reactivation was detected more frequently in the TG than in the brain stem and, in all but one case, the amount of virus recovered was greater in the TG than that detected in the brain stem. Viral protein positive neurons were observed in the TG, but a cellular source for reactivation in the brain stem was not identified, despite serially sectioning and examining the entire tissue (0/6 brain stems). These findings suggest that infectious virus detected in the brain stem is primarily the result of transport of reactivated virus from the TG into the brain stem. Latent herpes simplex virus (HSV) DNA has been detected in the central nervous systems (CNS) of humans postmortem, and infection with HSV has been correlated with the development of neurodegenerative diseases. However, whether HSV can directly reactivate in the CNS and/or infectious virus can be transported to the CNS following reactivation in peripheral ganglia has been unclear. In this study, infectious virus was recovered from both the trigeminal ganglia and the brain stem of latently infected mice following a reactivation stimulus, but a higher frequency of reactivation and increased titers of infectious virus were recovered from the trigeminal ganglia. Viral proteins were detected in neurons of the trigeminal ganglia, but a cellular source of infectious virus could not be identified in the brain stem. These results suggest that infectious virus is transported from the ganglia to the CNS following reactivation but do not exclude the potential for direct reactivation in the CNS.
单纯疱疹病毒 (HSV) 在周围神经系统和中枢神经系统 (CNS) 的神经元中建立潜伏。越来越多的证据表明,HSV 在神经系统中的潜伏和再激活有可能促进神经退行性过程。了解这是如何发生的是一个重要的人类健康目标。在小鼠模型中,外周神经系统中的病毒再激活,由高热应激触发,已经在频率和细胞类型方面得到了很好的描述。然而,中枢神经系统中再激活的特征非常有限。此外,仍不清楚在外周神经系统中再激活的病毒是否以感染形式被运送到中枢神经系统,这种情况发生的频率是多少,以及哪些参数是这一过程效率和结果的基础。在这项研究中,使用直接检测的等效敏感性,从同一潜伏感染动物的三叉神经节 (TG) 和脑干中定量检测再激活。在 TG 中检测到再激活的频率高于脑干,在所有但一个病例中,从 TG 中回收的病毒量大于从脑干中检测到的病毒量。在 TG 中观察到病毒蛋白阳性神经元,但未鉴定出脑干中再激活的细胞来源,尽管对整个组织进行了连续切片和检查 (0/6 个脑干)。这些发现表明,在脑干中检测到的感染性病毒主要是从 TG 中再激活的病毒运送到脑干的结果。在人类死后的中枢神经系统 (CNS) 中已经检测到潜伏性单纯疱疹病毒 (HSV) DNA,并且 HSV 感染与神经退行性疾病的发展相关。然而,HSV 是否可以直接在中枢神经系统中再激活,以及感染性病毒是否可以在外周神经节再激活后运送到中枢神经系统尚不清楚。在这项研究中,在潜伏感染小鼠的三叉神经节和脑干中均从再激活刺激中回收感染性病毒,但从三叉神经节中回收的再激活频率更高,感染性病毒滴度更高。在三叉神经节的神经元中检测到病毒蛋白,但在脑干中无法鉴定出感染性病毒的细胞来源。这些结果表明,感染性病毒从神经节运送到中枢神经系统,但不排除中枢神经系统直接再激活的可能性。